These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21424083)

  • 1. Histoenzymatic and immunohistochemical study during antiangiogenetic treatment in breast cancer cells.
    Pallag A; Ardelean A; Roşca E; Pop O; Suciu R
    Rom J Morphol Embryol; 2011; 52(1 Suppl):403-7. PubMed ID: 21424083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the effects of treatment in colon cancer cells using immunohistochemical and histoenzymatic techniques.
    Pallag A; Roşca E; ţiŢ DM; MuŢiu G; Bungău SG; Pop OL
    Rom J Morphol Embryol; 2015; 56(3):1103-9. PubMed ID: 26662146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy.
    Premkumar VG; Yuvaraj S; Sathish S; Shanthi P; Sachdanandam P
    Vascul Pharmacol; 2008; 48(4-6):191-201. PubMed ID: 18407793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
    Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
    Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
    Morabito A; Sarmiento R; Bonginelli P; Gasparini G
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
    Ademuyiwa FO; Miller KD
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic therapies in breast cancer.
    Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
    Lyons JM; Anthony CT; Thomson JL; Woltering EA
    Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets for breast cancer therapy and prevention.
    Bange J; Zwick E; Ullrich A
    Nat Med; 2001 May; 7(5):548-52. PubMed ID: 11329054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.
    Yu W; Sanders BG; Kline K
    Cancer Res; 2003 May; 63(10):2483-91. PubMed ID: 12750270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy in the management of breast cancer.
    Wu Y; Sun WL; Feng JF
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer.
    Vleugel MM; Greijer AE; Bos R; van der Wall E; van Diest PJ
    Hum Pathol; 2006 Jun; 37(6):668-74. PubMed ID: 16733206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer: the role of angiogenesis and antiangiogenic therapy.
    Miller KD; Dul CL
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1071-86, ix. PubMed ID: 15474336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histo- and cytochemical enzymatic characteristics of breast cancer].
    Kogan EA
    Arkh Patol; 1979; 41(11):19-25. PubMed ID: 518361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM; Lau N; Guha A
    Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
    Mele T; Generali D; Fox S; Brizzi MP; Bersiga A; Milani M; Allevi G; Bonardi S; Aguggini S; Volante M; Dogliotti L; Bottini A; Harris A; Berruti A
    Breast Cancer Res Treat; 2010 Oct; 123(3):795-804. PubMed ID: 20680681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
    Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.